FI2839836T4 - Probiootit käytettäväksi vähennettäessä hengityselintaudin oireita - Google Patents

Probiootit käytettäväksi vähennettäessä hengityselintaudin oireita Download PDF

Info

Publication number
FI2839836T4
FI2839836T4 FIEP14186663.2T FI14186663T FI2839836T4 FI 2839836 T4 FI2839836 T4 FI 2839836T4 FI 14186663 T FI14186663 T FI 14186663T FI 2839836 T4 FI2839836 T4 FI 2839836T4
Authority
FI
Finland
Prior art keywords
culture
child
lactis
respiratory disease
acidophilus
Prior art date
Application number
FIEP14186663.2T
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Gregory Leyer
Arthur Ouwehand
Original Assignee
Int N&H Denmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39268947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI2839836(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Int N&H Denmark Aps filed Critical Int N&H Denmark Aps
Application granted granted Critical
Publication of FI2839836T4 publication Critical patent/FI2839836T4/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FIEP14186663.2T 2006-10-02 2024-04-11 Probiootit käytettäväksi vähennettäessä hengityselintaudin oireita FI2839836T4 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84866206P 2006-10-02 2006-10-02

Publications (1)

Publication Number Publication Date
FI2839836T4 true FI2839836T4 (fi) 2024-08-26

Family

ID=39268947

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP14186663.2T FI2839836T4 (fi) 2006-10-02 2024-04-11 Probiootit käytettäväksi vähennettäessä hengityselintaudin oireita

Country Status (13)

Country Link
US (5) US20100040579A1 (https=)
EP (2) EP2068899B1 (https=)
JP (3) JP5896589B2 (https=)
KR (2) KR101485200B1 (https=)
CN (1) CN101528244B (https=)
AU (1) AU2007302715B2 (https=)
BR (1) BRPI0719787A2 (https=)
DK (2) DK2839836T4 (https=)
ES (2) ES2650375T5 (https=)
FI (1) FI2839836T4 (https=)
MX (1) MX2009003260A (https=)
PL (2) PL2068899T3 (https=)
WO (1) WO2008042101A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5538554B2 (ja) 2009-12-02 2014-07-02 ケーエムダブリュ・インコーポレーテッド デバイス選択構造
JP5885287B2 (ja) * 2010-09-02 2016-03-15 アサヒカルピスウェルネス株式会社 インフルエンザの予防および／または治療剤
CN103220921B (zh) * 2010-10-15 2015-12-16 科.汉森有限公司 免疫佐剂
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2455093A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
CN105722515A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
CN104957260B (zh) * 2014-03-07 2018-07-24 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
CN107427054A (zh) 2015-03-05 2017-12-01 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
US20200289804A1 (en) 2019-02-21 2020-09-17 Olympus Corporation Flora treatment
EP4040984B1 (en) 2019-09-25 2026-02-18 Tall Goods, LLC Methods for producing probiotics fortified avian eggs and egg products and formulations thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007A (en) * 1845-04-22 Improvement in separating tannin and coloring-matter in quercitron-bark
AU5113798A (en) * 1996-11-29 1998-06-22 Bio K & International Inc. Lactic ferment comprising a particular strain of (lactobacillus acidophilus) and use thereof
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
EP1549151A1 (en) 2002-10-11 2005-07-06 Wyeth Nutritional formulations containing synbiotic substances
AU2004298384A1 (en) * 2003-12-17 2005-06-30 N.V. Nutricia Lactic acid producing bacteria and lung function
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
US7862808B2 (en) † 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
ES2348403T3 (es) * 2005-02-15 2010-12-03 Barry R. Goldin Un alimento que contiene un probiotico y un beta-glucano aislado y metodos de uso del mismo.
US20070020249A1 (en) * 2005-04-29 2007-01-25 Downs Bernard W Compositions for prevention and treatement of symptoms of gastrointestinal distress
AU2006297896B2 (en) 2005-10-06 2011-12-08 Probi Ab Use of lactobacillus for treatment of autoimmune diseases

Also Published As

Publication number Publication date
PL2839836T5 (pl) 2025-11-17
US20100040579A1 (en) 2010-02-18
WO2008042101A3 (en) 2009-04-09
AU2007302715B2 (en) 2013-01-31
DK2839836T3 (en) 2017-12-04
JP2010505824A (ja) 2010-02-25
CN101528244A (zh) 2009-09-09
PL2068899T3 (pl) 2015-12-31
JP5896589B2 (ja) 2016-03-30
CN101528244B (zh) 2012-01-11
JP2014058558A (ja) 2014-04-03
KR20090063222A (ko) 2009-06-17
KR20140002069A (ko) 2014-01-07
US20180000875A1 (en) 2018-01-04
DK2068899T3 (da) 2015-09-28
DK2839836T4 (da) 2024-08-26
BRPI0719787A2 (pt) 2014-11-25
US20230256037A1 (en) 2023-08-17
PL2839836T3 (pl) 2018-02-28
EP2068899A2 (en) 2009-06-17
MX2009003260A (es) 2009-05-11
AU2007302715A1 (en) 2008-04-10
EP2839836A1 (en) 2015-02-25
EP2068899B1 (en) 2015-07-01
ES2650375T5 (en) 2025-02-03
US20140356329A1 (en) 2014-12-04
KR101485200B1 (ko) 2015-01-26
EP2839836B2 (en) 2024-06-26
KR101474188B1 (ko) 2014-12-17
ES2650375T3 (es) 2018-01-18
WO2008042101A2 (en) 2008-04-10
ES2547480T3 (es) 2015-10-06
EP2839836B1 (en) 2017-08-30
JP2016128478A (ja) 2016-07-14
US20200316145A1 (en) 2020-10-08

Similar Documents

Publication Publication Date Title
FI2839836T4 (fi) Probiootit käytettäväksi vähennettäessä hengityselintaudin oireita
EP1623046A4 (en) Compositions and methods for treating severe acute respiratory syndrome (SARS)
DE602004006133D1 (de) Neue galactooligosaccharidzusammensetzung und herstellung davon
JP2014528474A5 (https=)
BR0313185A (pt) Probióticos para funções neuromusculares intestinais
EP2510811A3 (en) Use of nutritional compositions for preventing disorders
JP2002532432A5 (https=)
JP2009517473A5 (https=)
MY153062A (en) Methods of treating gastrointestinal disorders independent of the intake of food
BR112014000322A2 (pt) "probióticos, e seus usos"
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
JP2008538288A5 (https=)
McElroy et al. The development of oral lesions in lambs naturally infected with orf virus
JP2013510169A5 (https=)
WO2008085875A3 (en) R-zileuton for use in conditions associated with increased 5-lipoxygenase and/or leukotriene activity (eg asthma)
JP2010505824A5 (https=)
HRP20151091T1 (hr) UPORABA 24-norUDCA
HRP20131150T1 (hr) Pimobendan za uporabu u lijeäśenju hipertrofiäśne kardiomiopatije kod maäśaka
JP2009513663A5 (https=)
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
JP2014505679A5 (https=)
WO2009005046A1 (ja) ミゾリビンを含有する潰瘍性大腸炎治療薬
WO2009019307A3 (en) Oral calcitonin compositions and applications thereof
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
CA2533181A1 (en) Use of dapsone as neuroprotector in the brain stroke